Institutional investors purchased a net $41.8 thousand shares of NBY during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 3.52% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBITRONIX LP Bought 161.2 Thousand shares of NovaBay Pharmaceuticals I...